Cargando…
Parsplana vitrectomy alone versus parsplana vitrectomy combined with phacoemulsification for the treatment of rhegmatogenous retinal detachment: a randomized study
BACKGROUND: To compare parsplana vitrectomy (PPV) with and without phacoemulsification to treat rhegmatogenous retinal detachment (RRD). METHODS: Subjects aged 48–65 years with RRD in a phakic eye due to superior retinal tears with an overall extension of retinal breaks < 90° underwent to PPV alo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091481/ https://www.ncbi.nlm.nih.gov/pubmed/33941122 http://dx.doi.org/10.1186/s12886-021-01954-y |
_version_ | 1783687494458408960 |
---|---|
author | Mora, Paolo Favilla, Stefania Calzetti, Giacomo Berselli, Giulia Benatti, Lucia Carta, Arturo Gandolfi, Stefano Tedesco, Salvatore A. |
author_facet | Mora, Paolo Favilla, Stefania Calzetti, Giacomo Berselli, Giulia Benatti, Lucia Carta, Arturo Gandolfi, Stefano Tedesco, Salvatore A. |
author_sort | Mora, Paolo |
collection | PubMed |
description | BACKGROUND: To compare parsplana vitrectomy (PPV) with and without phacoemulsification to treat rhegmatogenous retinal detachment (RRD). METHODS: Subjects aged 48–65 years with RRD in a phakic eye due to superior retinal tears with an overall extension of retinal breaks < 90° underwent to PPV alone (group A); or PPV plus phacoemulsification (phacovitrectomy, PCV, group B). Post-operative follow-up visits occurred at 1 week, 1 month (m1), 3 months (m3), and 6 months (m6) after surgery. The main outcome was the rate of retinal reattachment. Secondary outcomes included best-corrected visual acuity (BCVA), intraocular pressure (IOP), central macular thickness (CMT), and cataract progression (in the lens-sparing [PPV-alone] group). RESULTS: In this initial phase of the study a total of 59 patients (mean age: 55 years, 59 eyes) were enrolled: 29 eyes in group A and 30 eyes in group B. Both groups had similar gas tamponade. During the follow-up there were three cases of RRD recurrence in group A and one in group B. The relative risk of recurrence in group A was 3.22 times higher but the difference was not significant (p = 0.3). The two groups were also similar in terms of BCVA and IOP variation. At m3, CMT was significantly higher in group B (p = 0.014). In group A, cataract progression was significant at m6 (p = 0.003). CONCLUSIONS: In a cohort of RRD patients selected according to their preoperative clinical characteristics, PPV was comparable to PCV in terms of the rate of retinal reattachment after 6 months. TRIAL REGISTRATION: ISRCTN15940019. Date registered: 15/01/2021 (retrospectively registered). |
format | Online Article Text |
id | pubmed-8091481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80914812021-05-04 Parsplana vitrectomy alone versus parsplana vitrectomy combined with phacoemulsification for the treatment of rhegmatogenous retinal detachment: a randomized study Mora, Paolo Favilla, Stefania Calzetti, Giacomo Berselli, Giulia Benatti, Lucia Carta, Arturo Gandolfi, Stefano Tedesco, Salvatore A. BMC Ophthalmol Research Article BACKGROUND: To compare parsplana vitrectomy (PPV) with and without phacoemulsification to treat rhegmatogenous retinal detachment (RRD). METHODS: Subjects aged 48–65 years with RRD in a phakic eye due to superior retinal tears with an overall extension of retinal breaks < 90° underwent to PPV alone (group A); or PPV plus phacoemulsification (phacovitrectomy, PCV, group B). Post-operative follow-up visits occurred at 1 week, 1 month (m1), 3 months (m3), and 6 months (m6) after surgery. The main outcome was the rate of retinal reattachment. Secondary outcomes included best-corrected visual acuity (BCVA), intraocular pressure (IOP), central macular thickness (CMT), and cataract progression (in the lens-sparing [PPV-alone] group). RESULTS: In this initial phase of the study a total of 59 patients (mean age: 55 years, 59 eyes) were enrolled: 29 eyes in group A and 30 eyes in group B. Both groups had similar gas tamponade. During the follow-up there were three cases of RRD recurrence in group A and one in group B. The relative risk of recurrence in group A was 3.22 times higher but the difference was not significant (p = 0.3). The two groups were also similar in terms of BCVA and IOP variation. At m3, CMT was significantly higher in group B (p = 0.014). In group A, cataract progression was significant at m6 (p = 0.003). CONCLUSIONS: In a cohort of RRD patients selected according to their preoperative clinical characteristics, PPV was comparable to PCV in terms of the rate of retinal reattachment after 6 months. TRIAL REGISTRATION: ISRCTN15940019. Date registered: 15/01/2021 (retrospectively registered). BioMed Central 2021-05-03 /pmc/articles/PMC8091481/ /pubmed/33941122 http://dx.doi.org/10.1186/s12886-021-01954-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Mora, Paolo Favilla, Stefania Calzetti, Giacomo Berselli, Giulia Benatti, Lucia Carta, Arturo Gandolfi, Stefano Tedesco, Salvatore A. Parsplana vitrectomy alone versus parsplana vitrectomy combined with phacoemulsification for the treatment of rhegmatogenous retinal detachment: a randomized study |
title | Parsplana vitrectomy alone versus parsplana vitrectomy combined with phacoemulsification for the treatment of rhegmatogenous retinal detachment: a randomized study |
title_full | Parsplana vitrectomy alone versus parsplana vitrectomy combined with phacoemulsification for the treatment of rhegmatogenous retinal detachment: a randomized study |
title_fullStr | Parsplana vitrectomy alone versus parsplana vitrectomy combined with phacoemulsification for the treatment of rhegmatogenous retinal detachment: a randomized study |
title_full_unstemmed | Parsplana vitrectomy alone versus parsplana vitrectomy combined with phacoemulsification for the treatment of rhegmatogenous retinal detachment: a randomized study |
title_short | Parsplana vitrectomy alone versus parsplana vitrectomy combined with phacoemulsification for the treatment of rhegmatogenous retinal detachment: a randomized study |
title_sort | parsplana vitrectomy alone versus parsplana vitrectomy combined with phacoemulsification for the treatment of rhegmatogenous retinal detachment: a randomized study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091481/ https://www.ncbi.nlm.nih.gov/pubmed/33941122 http://dx.doi.org/10.1186/s12886-021-01954-y |
work_keys_str_mv | AT morapaolo parsplanavitrectomyaloneversusparsplanavitrectomycombinedwithphacoemulsificationforthetreatmentofrhegmatogenousretinaldetachmentarandomizedstudy AT favillastefania parsplanavitrectomyaloneversusparsplanavitrectomycombinedwithphacoemulsificationforthetreatmentofrhegmatogenousretinaldetachmentarandomizedstudy AT calzettigiacomo parsplanavitrectomyaloneversusparsplanavitrectomycombinedwithphacoemulsificationforthetreatmentofrhegmatogenousretinaldetachmentarandomizedstudy AT berselligiulia parsplanavitrectomyaloneversusparsplanavitrectomycombinedwithphacoemulsificationforthetreatmentofrhegmatogenousretinaldetachmentarandomizedstudy AT benattilucia parsplanavitrectomyaloneversusparsplanavitrectomycombinedwithphacoemulsificationforthetreatmentofrhegmatogenousretinaldetachmentarandomizedstudy AT cartaarturo parsplanavitrectomyaloneversusparsplanavitrectomycombinedwithphacoemulsificationforthetreatmentofrhegmatogenousretinaldetachmentarandomizedstudy AT gandolfistefano parsplanavitrectomyaloneversusparsplanavitrectomycombinedwithphacoemulsificationforthetreatmentofrhegmatogenousretinaldetachmentarandomizedstudy AT tedescosalvatorea parsplanavitrectomyaloneversusparsplanavitrectomycombinedwithphacoemulsificationforthetreatmentofrhegmatogenousretinaldetachmentarandomizedstudy |